Hypertension Secondary to Contraceptive Agents

This publication has 54 references indexed in Scilit:

• ALTERED PLASMA LIPID AND LIPOPROTEIN LEVELS ASSOCIATED WITH ORAL CONTRACEPTIVE AND ŒSTROGEN USE: Report from the Medications Working Group of the Lipid Research Clinics Program
  The Lancet, 1979
• Plasma renin activity, reactivity, concentration and substrate following hypertension during pregnancy. Effect of oral contraceptive agents.
  Hypertension, 1979
• COMPARISON OF EFFECTS OF DIFFERENT COMBINED ORAL-CONTRACEPTIVE FORMULATIONS ON CARBOHYDRATE AND LIPID METABOLISM
  The Lancet, 1979
• ORAL-CONTRACEPTIVE USE IN RELATION TO MYOCARDIAL INFARCTION
  The Lancet, 1979
• CARDIOVASCULAR-DISEASE MORTALITY TRENDS AND ORAL-CONTRACEPTIVE USE IN YOUNG WOMEN
  The Lancet, 1976
• Cardiovascular risk and use of estrogens or estrogen-progestagen combinations. Stanford three-community study
  JAMA, 1976
• Contraceptive steroids and hypertension
  Journal of Steroid Biochemistry, 1975
• Plasma dopamine-beta-hydroxylase activity in oral contraceptive hypertension.
  Circulation, 1975
• Malignant hypertension associated with use of oral contraceptives.
  Heart, 1975
• Oral contraceptives, pregnancy, and blood pressure
  Published by American Medical Association (AMA) ,1972